Ian Johnston

RT @amy_borrett: Do Gen Z have it harder than any other generation? I dug into the data on housing, jobs and mental health for @FT to see i…

"Customers pay to spit into a tube, mail it back and learn what is written in their genes... the problem is that after the big reveal, there is not much scope for recurring business" Sharp follow-up to our piece on 23andMe's problems from FT's Lex: https://t.co/sg55fuk2K6

23andMe was the toast of Silicon Valley in 2021. Now lawyers suing it over a data breach of 7mn users want a cut-price compensation deal before it runs out of cash Story on the genetics testing company with @stephistacey and @GeorgeNHammond: https://t.co/SKF3uWyVe4

RT @mroliverbarnes: Ladies and gentlemen, @FT data genius @jburnmurdoch has called it: weight loss drugs are causing a fall in obesity rate…

RT @FT: Roche data shows stomach-churning side effects of weight-loss drugs https://t.co/NSg5yq2nlr

RT @mroliverbarnes: Haunting quote: “Pancreatic cancer does not have patient advocates because they all die,” said Julie Fleshman, chief ex…

RT @mroliverbarnes: A little known tale: Swiss pharma group Roche, which is pitching itself to investors as a new weight loss contender, pa…

RT @ftenergy: How Big Tech is quietly trying to reshape how pollution is reported https://t.co/jFabTIu0oH

AstraZeneca vaccine project in doubt as UK Treasury seeks to cut state aid https://t.co/7gSYYLrcZS via @ft

RT @AndyBounds: EU warned new medical trial rules will slow approval of vital treatments via @FT with ⁦@ian_c_johnston⁩ https://t.co/5vuu…

RT @Laura_K_Hughes: A rising number of women are seeking private IVF treatments in England as the NHS rolls back funding for fertility serv…

RT @samjoiner: NEW: Inside the race to make the world’s fastest running shoes. We worked with @lumafield to CT-scan the latest Nike and A…

AstraZeneca calls on Labour to change rules on innovative drug pricing Stretched healthcare systems are assessing whether they can afford the high cost of innovative new treatments that have boosted pharmaceutical companies’ sales. https://t.co/LSk6DGwnN1 via @ft

More FT pharma new: US recommendations for the world's first RSV vaccines will shrink their sales, in a blow to jab makers GSK, Pfizer and Moderna https://t.co/PUehrvPxYx via @ft

The NHS has prescribed weight loss drug Wegovy far less than expected since its UK launch, leaving patients on waiting lists while wealthier users pay out of pocket 💉 New in ⁦@FT⁩ with ⁦@clara__murray⁩ https://t.co/uDIVfBnK9j

RT @HenryJFoy: Von der Leyen commission unlawfully concealed Covid vaccine contracts details, court finds, in legal blow to her crunch re-e…

Great read from @akilazoe on a worrying legacy of France's elections: "The campaign emboldened extremists at a time when tensions in French society were already running high. Minorities were the first to pay the price" https://t.co/7S5Y7lzoMU via @financialtimes